高级检索

新型地氯雷他定衍生物的合成,生物活性与分子对接

Synthesis,biological evaluation and molecule docking of novel desloratadine derivatives

  • 摘要: 以三环类组胺H1受体拮抗剂地氯雷他定为先导化合物,设计并合成了7个地氯雷他定衍生物,其结构均通过核磁共振氢谱和高分辨质谱表征确定。豚鼠回肠收缩实验显示:两性化合物 9a 拮抗组胺H1受体的活性高于阳性对照药物地氯雷他定。化合物 9ahERG的抑制活性较弱,并且对豚鼠心率以及心电图各个间期的影响较小,提示其不具有潜在的心脏毒性。

     

    Abstract: Seven target compounds were designed and synthesized according to the structure of lead compound—desloratadine.The structures of the compounds were identified by 1H NMR and HR-MS.The in vitro results based on histamine-induced contraction of guiea-pig ileum showed that zwitterionic compound 9c had stronger antihistamine activity than positive control desloratadine.The human ether-à-go-go related gene (hERG)inhibition and guinea-pig langendorff model indicated that compound 9a had low inhibitory activity on hERG and yet no effect on the period of electrocardiogram,demonstrating that compound 9a may not cause the potential cardiotoxicity.

     

/

返回文章
返回